Tag: Parkinson’s Disease
Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies
Background Chimeric antigen receptor (CAR)-T cell therapy has emerged as a transformative modality in the treatment of patients with cancer. However, it is increasingly evident that this therapeutic approach is not without its challenges. The unique nature of CAR-T cells as living drugs introduces a distinct set of side effects. As the application of CAR-T… Continue reading Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies
Diener’s Top 12 Neurology Stories in 2024
Prof Christoph Diener picks his top neurology publications in 2024 covering Alzheimer’s, stroke, Parkinson’s, migraine, glioblastoma, long COVID, and the GLP-1 drugs. Medscape Neurology
The crucial role of ‘chaperones’ in maintaining neuronal function
A team of researchers from the University of Massachusetts Amherst is the first to show how proteins called “chaperones” are vital in ensuring that neurons can transmit signals to one another. When this neurotransmission breaks down, devastating diseases such as Alzheimer’s and Parkinson’s along with many others, can occur. The team’s research provides a new… Continue reading The crucial role of ‘chaperones’ in maintaining neuronal function
Researchers highlight role ‘workhorse protein’ plays in keeping nervous system running smoothly
Correction: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons
Peptide-guided nanoparticles deliver mRNA to neurons
Engineers have modified lipid nanoparticles (LNPs) — the revolutionary technology behind the COVID-19 mRNA vaccines — to not only cross the blood-brain barrier (BBB) but also to target specific types of cells, including neurons. This breakthrough marks a significant step toward potential next-generation treatments for neurological diseases like Alzheimer’s and Parkinson’s.
‘Chance Finding’ a True Breakthrough for Spinal Cord Injury?
Deep brain stimulation of the lateral hypothalamus improves walking and promotes recovery in patients with spinal cord injury, new research showed. Medscape Medical News
Penn-led consortium to advance imaging of brain diseases
A Penn Medicine-led consortium of radiology and chemistry researchers across the United States will advance imaging of diseases like Parkinson’s by testing radiotracers they identified that illuminate α-synuclein (αSyn) or 4R tau proteins on positron emission tomography (PET) scans. Armed with a five-year, $30 million grant from the National Institutes of Neurological Disease and Stroke,… Continue reading Penn-led consortium to advance imaging of brain diseases
[ASAP] Biomimetic Approach for Optimal Designing of the Shape and Controlled Release of Therapeutics from Tricompartmental Microcarriers for Managing Parkinson’s Disease
ACS Applied Bio MaterialsDOI: 10.1021/acsabm.4c01149